Providing a diverse range of perspectives from bullish to bearish, 11 analysts have published ratings on CVS Health (NYSE:CVS) in the last three months. The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months. The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $62.27, a high estimate of $68.00, and a low estimate of $58.00. A negative shift in sentiment is evident as analysts have decreased the average price target by 0.14%. Breaking Dow…